ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681163 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681163; 2) Community: the network communities that were significantly associated with the response to NSC 681163; 3) Molecule: the relationships between components within communities and NSC 681163; 4) MDR: the compounds that were significantly associated with the NSC 681163.

NSC Compound Enrichment Correlation
NSC 626868 Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- 0.0337307532806868 0.1328971
NSC 628185 Null 0.0337307532806868 0.084462372
NSC 638302 Null 0.0337307532806868 0.32157293
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.0337307532806868 0.24905358
NSC 644474 Null 0.0337307532806868 0.044814952
NSC 657346 Null 0.0337307532806868 0.36389357
NSC 666038 Piperidinone, 1-methyl-3,5-bis[(2-nitrophenyl) methylene]-, hydrochloride 0.0337307532806868 0.38994235
NSC 681640 Camptothecin Derivative 0.0399098711718627 0.32651249
NSC 681642 Camptothecin Derivative 0.0399098711718627 0.35571596
NSC 682429 2-(1-Propynyl)-3,17.beta.-estradiol 0.0399098711718627 0.40587762
Total:28  Current:19    [First] [Prev] [Next] [Last]